Author

Kathryn D. Cook

Observed name: Kathryn Cook

Institutions: Mayo Clinic, Mayo Clinic Comprehensive Cancer Center (Minnesota)

Observed institutions: Mayo Clinic, Mayo Clinic Comprehensive Cancer Center (Minnesota)

ORCID: 0000-0002-4490-9377

Observed ORCID: 0000-0002-4490-9377

OpenAlex ID: A5089568587

Understanding Verbosity: Funding Source and the Length of Consent Forms for Cancer Clinical Trials

2020 · Quyen Duong, Sumithra J. Mandrekar, et al. · Journal of Cancer Education · 12

Nanoliposomal irinotecan (Nal-IRI)-based chemotherapy after irinotecan -based chemotherapy in patients with pancreas cancer

2020 · Caleb J. Smith, Tanios S. Bekaii-Saab, et al. · Pancreatology · 8

Alpelisib-induced hyperglycemia in older patients with breast Cancer: Qualitative findings

2021 · Kathryn Cook, Yahya Almodallal, et al. · Journal of Geriatric Oncology · 5

Observations with alpelisib in older patients (≥ 65 year of age) with breast cancer in a non-clinical trial setting

2021 · Yahya Almodallal, Jennifer G. Le-Rademacher, et al. · Breast Cancer Research and Treatment · 4

How Did a Multi-Institutional Trial Show Feasibility of Electronic Data Capture in Older Patients With Cancer? Results From a Multi-Institutional Qualitative Study (Alliance A171902)

2021 · Nichole A. Martin, Elizabeth S. Harlos, et al. · JCO Clinical Cancer Informatics · 4

Metastatic or suspected metastatic cancer in patients 90 years of age or older: A single-institution, multi-site study

2021 · Yahya Almodallal, Kathryn D. Cook, et al. · Journal of Geriatric Oncology · 4

Randomized, Double-Blind Trial on the Impact of Word Count in Cancer Clinical Trial Consent Forms

2021 · Yahya Almodallal, Quyen Duong, et al. · JCO Oncology Practice · 3

Nanoliposomal irinotecan-based chemotherapy after regular irinotecan-based chemotherapy in patients with pancreas cancer.

2021 · Caleb J Smith, Tanios S. Bekaii-Saab, et al. · Journal of Clinical Oncology · 1

Works count: 8

Citation count: 41

H-index: 4

I10-index: 1